NR3C2 and Obesity: Furthermore, a more recent study in humans also indicates a positive correlation between mineralocorticoid receptor antagonism and BAT thermogenesis (118), suggesting the potential therapeutic benefit of mineralocorticoid receptor antagonism on obesity.